Shay Shemesh - Apr 1, 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chief Dev. & Ops. Officer
Signature
/s/ Shay Shemesh
Stock symbol
NVCT
Transactions as of
Apr 1, 2022
Transactions value $
$0
Form type
4
Date filed
4/5/2022, 04:46 PM
Previous filing
Feb 8, 2022
Next filing
May 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Award $0 +60K +5.09% $0.00 1.24M Apr 1, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units will vest according to the following schedule: one-third on each of 4/1/2023, 4/1/2024, and 4/1/2025.
F2 Includes 48,399 shares of restricted stock and 60,000 restricted stock units.